Schmidt, Vanessa Henrika
[VerfasserIn]
;
Krüger, William H.
[AkademischeR BetreuerIn];
Hilgendorf, Inken
[AkademischeR BetreuerIn]Universität Greifswald
End of life care nach allogener Stammzelltransplantation
Allogenic stem cell transplantation may cure approximately 50% of patients, however, the other 50% could benefit from palliative care medicine at the end of life. The needs of these patients may differ from those of patients suffering from incurable solid tumours and are not comprehensively evaluated so far. To address this question, data charts from 123 patients who have died after allogenic stem cell transplantation were extracted.